The Human Evidence Problem Here's the honest gap: there are essentially no completed, published, peer-reviewed randomized controlled trials of BPC-157 in humans for any indication
Qu pasa cuando dejas de tomar creatina
March 3rd, 2026: Federal Judge Appoints Leadership for GLP1 Vision Loss Lawsuits Multiple lawsuits alleging vision loss from GLP1 drugs, including Ozempic, Wegovy, and Mounjaro have been consolidated into a multidistrict litigation in the Eastern District of Pennsylvania, the same court responsible for handling GLP-1 lawsuits involving gastrointestinal injuries
Dermatologists and ethical practitioners emphasize that skin health and self-love come first
Samen met hoofdpijn en vermoeidheid treedt dit op bij 10 tot 30 op de 100 personen (Lareb, 2025)
Training two to three days a week allows for sufficient stimulus without overwhelming the body's recovery systems, which may already be taxed by the caloric deficit